Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac vs Fentanyl PCA for PONV in MVD
NCT05189704Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketorolac in postoperative pain (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Postoperative nausea and vomiting at 48 hours. Status: unknown.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05189704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05189704.